Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Jan;87(1):246–250. doi: 10.1073/pnas.87.1.246

gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors.

T V Dam 1, Y Takeda 1, J E Krause 1, E Escher 1, R Quirion 1
PMCID: PMC53239  PMID: 1688655

Abstract

The presence of N-terminally extended forms of neurokinin A has recently been reported in the mammalian brain. Among them, gamma-preprotachykinin-(72-92)-peptide amide [gamma-PPT-(72-92)-NH2], a peptide derived by posttranslational processing of gamma-preprotachykinin, is most prominent. We report here that this peptide most likely acts on neurokinin-2 receptor sites since neurokinin A (a putative neurokinin-2 agonist) and gamma-PPT-(72-92)-NH2 are potent competitors of 125I-labeled gamma-PPT-(72-92)-NH2 binding whereas selective neurokinin-1 and -3 agonists are not. Moreover, the distribution of 125I-labeled gamma-PPT-(72-92)-NH2 and 125I-labeled neurokinin A binding sites are very similar in rat brain. On the other hand, 125I-labeled Bolton-Hunter-substance P (a neurokinin-1 ligand) and 125I-labeled Bolton-Hunter-eledoisin (a neurokinin-3 ligand) binding sites are differentially located in this tissue. Thus, it appears that gamma-PPT-(72-92)-NH2 binds to neurokinin-2 receptors and should be considered as a putative endogenous ligand for this receptor class.

Full text

PDF
246

Images in this article

248Image
on p.248
248Image
on p.248
248Image
on p.248
248Image
on p.248
248Image
on p.248
248Image
on p.248
249Image
on p.249
249Image
on p.249
249Image
on p.249
249Image
on p.249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akil H., Watson S. J., Young E., Lewis M. E., Khachaturian H., Walker J. M. Endogenous opioids: biology and function. Annu Rev Neurosci. 1984;7:223–255. doi: 10.1146/annurev.ne.07.030184.001255. [DOI] [PubMed] [Google Scholar]
  2. Arai H., Emson P. C. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 1986 Dec 10;399(2):240–249. doi: 10.1016/0006-8993(86)91514-3. [DOI] [PubMed] [Google Scholar]
  3. Beaujouan J. C., Saffroy M., Petitet F., Torrens Y., Glowinski J. Neuropeptide K, scyliorhinin I and II: new tools in the tachykinin receptor field. Eur J Pharmacol. 1988 Jul 7;151(2):353–354. doi: 10.1016/0014-2999(88)90826-6. [DOI] [PubMed] [Google Scholar]
  4. Beaujouan J. C., Torrens Y., Saffroy M., Glowinski J. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Neuroscience. 1986 Aug;18(4):857–875. doi: 10.1016/0306-4522(86)90105-3. [DOI] [PubMed] [Google Scholar]
  5. Bergström L., Torrens Y., Saffroy M., Beaujouan J. C., Lavielle S., Chassaing G., Morgat J. L., Glowinski J., Marquet A. [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J Neurochem. 1987 Jan;48(1):125–133. doi: 10.1111/j.1471-4159.1987.tb13136.x. [DOI] [PubMed] [Google Scholar]
  6. Buck S. H., Burcher E., Shults C. W., Lovenberg W., O'Donohue T. L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science. 1984 Nov 23;226(4677):987–989. doi: 10.1126/science.6095447. [DOI] [PubMed] [Google Scholar]
  7. Buck S. H., Helke C. J., Burcher E., Shults C. W., O'Donohue T. L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides. 1986 Nov-Dec;7(6):1109–1120. doi: 10.1016/0196-9781(86)90141-5. [DOI] [PubMed] [Google Scholar]
  8. Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science. 1982 Jan 22;215(4531):413–415. doi: 10.1126/science.6120570. [DOI] [PubMed] [Google Scholar]
  9. Dam T. V., Escher E., Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res. 1988 Jun 21;453(1-2):372–376. doi: 10.1016/0006-8993(88)90181-3. [DOI] [PubMed] [Google Scholar]
  10. Drapeau G., D'Orléans-Juste P., Dion S., Rhaleb N. E., Rouissi N. E., Regoli D. Selective agonists for substance P and neurokinin receptors. Neuropeptides. 1987 Jul;10(1):43–54. doi: 10.1016/0143-4179(87)90088-6. [DOI] [PubMed] [Google Scholar]
  11. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  12. Kage R., McGregor G. P., Thim L., Conlon J. M. Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem. 1988 May;50(5):1412–1417. doi: 10.1111/j.1471-4159.1988.tb03024.x. [DOI] [PubMed] [Google Scholar]
  13. Kawaguchi Y., Hoshimaru M., Nawa H., Nakanishi S. Sequence analysis of cloned cDNA for rat substance P precursor: existence of a third substance P precursor. Biochem Biophys Res Commun. 1986 Sep 30;139(3):1040–1046. doi: 10.1016/s0006-291x(86)80282-0. [DOI] [PubMed] [Google Scholar]
  14. Kotani H., Hoshimaru M., Nawa H., Nakanishi S. Structure and gene organization of bovine neuromedin K precursor. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7074–7078. doi: 10.1073/pnas.83.18.7074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S., Hershey A. D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci U S A. 1987 Feb;84(3):881–885. doi: 10.1073/pnas.84.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Krause J. E., MacDonald M. R., Takeda Y. The polyprotein nature of substance P precursors. Bioessays. 1989 Feb-Mar;10(2-3):62–69. doi: 10.1002/bies.950100207. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. MacDonald M. R., McCourt D. W., Krause J. E. Posttranslational processing of alpha-, beta-, and gamma-preprotachykinins. Cell-free translation and early posttranslational processing events. J Biol Chem. 1988 Oct 15;263(29):15176–15183. [PubMed] [Google Scholar]
  19. Maggio J. E. Tachykinins. Annu Rev Neurosci. 1988;11:13–28. doi: 10.1146/annurev.ne.11.030188.000305. [DOI] [PubMed] [Google Scholar]
  20. Mantyh P. W., Gates T., Mantyh C. R., Maggio J. E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci. 1989 Jan;9(1):258–279. doi: 10.1523/JNEUROSCI.09-01-00258.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mantyh P. W., Maggio J. E., Hunt S. P. The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain. Eur J Pharmacol. 1984 Jul 13;102(2):361–364. doi: 10.1016/0014-2999(84)90269-3. [DOI] [PubMed] [Google Scholar]
  22. Nakanishi S. Substance P precursor and kininogen: their structures, gene organizations, and regulation. Physiol Rev. 1987 Oct;67(4):1117–1142. doi: 10.1152/physrev.1987.67.4.1117. [DOI] [PubMed] [Google Scholar]
  23. Nawa H., Hirose T., Takashima H., Inayama S., Nakanishi S. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature. 1983 Nov 3;306(5938):32–36. doi: 10.1038/306032a0. [DOI] [PubMed] [Google Scholar]
  24. Nawa H., Kotani H., Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984 Dec 20;312(5996):729–734. doi: 10.1038/312729a0. [DOI] [PubMed] [Google Scholar]
  25. Paterson S. J., Robson L. E., Kosterlitz H. W. Classification of opioid receptors. Br Med Bull. 1983 Jan;39(1):31–36. doi: 10.1093/oxfordjournals.bmb.a071787. [DOI] [PubMed] [Google Scholar]
  26. Quirion R., Dam T. V. Multiple tachykinin receptors in guinea pig brain. High densities of substance K (neurokinin A) binding sites in the substantia nigra. Neuropeptides. 1985 Jun;6(3):191–204. doi: 10.1016/0143-4179(85)90090-3. [DOI] [PubMed] [Google Scholar]
  27. Quirion R., Dam T. V. Ontogeny of substance P receptor binding sites in rat brain. J Neurosci. 1986 Aug;6(8):2187–2199. doi: 10.1523/JNEUROSCI.06-08-02187.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Quirion R., Weiss A. S. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists. Peptides. 1983 Jul-Aug;4(4):445–449. doi: 10.1016/0196-9781(83)90047-5. [DOI] [PubMed] [Google Scholar]
  29. Regoli D., Drapeau G., Dion S., D'Orléans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci. 1987 Jan 12;40(2):109–117. doi: 10.1016/0024-3205(87)90349-3. [DOI] [PubMed] [Google Scholar]
  30. Takeda Y., Krause J. E. Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation. Proc Natl Acad Sci U S A. 1989 Jan;86(1):392–396. doi: 10.1073/pnas.86.1.392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Takeda Y., Krause J. E. gamma-Preprotachykinin-(72-92)-peptide amide potentiates substance P-induced salivation. Eur J Pharmacol. 1989 Feb 28;161(2-3):267–271. doi: 10.1016/0014-2999(89)90858-3. [DOI] [PubMed] [Google Scholar]
  32. Tatemoto K., Lundberg J. M., Jörnvall H., Mutt V. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun. 1985 Apr 30;128(2):947–953. doi: 10.1016/0006-291x(85)90138-x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES